These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1968001)

  • 1. Do we need stress ulcer prophylaxis?
    Reines HD
    Crit Care Med; 1990 Mar; 18(3):344. PubMed ID: 1968001
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stress ulcer disease and its prevention].
    Gyr K; Meier R
    Schweiz Med Wochenschr; 1989 Apr; 119(13-14):423-9. PubMed ID: 2566200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term medical prophylaxis of peptic ulcer disease].
    Rohner HG
    Dtsch Med Wochenschr; 1986 Jan; 111(3):117-8. PubMed ID: 2866944
    [No Abstract]   [Full Text] [Related]  

  • 4. Stress ulcer prophylaxis: friend or foe?
    Macdonald JJ; Roberts JC; Washington S
    Br J Hosp Med (Lond); 2012 Apr; 73(4):238. PubMed ID: 22585209
    [No Abstract]   [Full Text] [Related]  

  • 5. Q: do all hospitalized patients need stress ulcer prophylaxis?
    Eisa N; Bazerbachi F; Alraiyes AH; Alraies MC
    Cleve Clin J Med; 2014 Jan; 81(1):23-5. PubMed ID: 24391103
    [No Abstract]   [Full Text] [Related]  

  • 6. Ranitidine and gastrointestinal bleeding in intensive care. Should prophylaxis against stress ulcer be abondoned for patients in intensive care.
    Preiser JC
    BMJ; 2001 Apr; 322(7292):995. PubMed ID: 11339222
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative studies on recurrence and relapse rate in peptic ulcer treated with various types of anti-ulcer agent; inhibitors of initiating factors causing peptic ulcer].
    Ishikawa M; Saito H; Sato J
    Nihon Rinsho; 1988 Jan; 46(1):69-78. PubMed ID: 2897486
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prophylaxis of stress ulcers].
    Kivilaakso E
    Duodecim; 1993; 109(3):237-42. PubMed ID: 7912180
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative efficacy of parenteral histamine (H2)-antagonists in acid suppression for the prevention of stress ulceration.
    Critchlow JF
    Am J Med; 1987 Dec; 83(6A):23-8. PubMed ID: 2892406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress ulcer prevention and histamine-2-receptor antagonists: leaps of faith or back to the drawing board?
    Freedman MD
    Crit Care Med; 1999 Jan; 27(1):13-4. PubMed ID: 9934877
    [No Abstract]   [Full Text] [Related]  

  • 11. Considerations for selection of parenteral histamine (H2)-receptor antagonists.
    Wolfe MM
    Am J Med; 1987 Dec; 83(6A):82-8. PubMed ID: 2892411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current management of patients with stress ulceration.
    O'Keefe G; Maier RV
    Adv Surg; 1996; 30():155-77. PubMed ID: 8960334
    [No Abstract]   [Full Text] [Related]  

  • 13. Histamine H2-receptor antagonists.
    Keithley JK
    Nurs Clin North Am; 1991 Jun; 26(2):361-73. PubMed ID: 1675461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of stress ulcer with acid decreasing drugs: an effective and sensible therapeutic approach? Arguments pro].
    von Kleist D
    Z Gastroenterol; 1991 Jan; 29 Suppl 1():10-1; discussion 14-5. PubMed ID: 1683731
    [No Abstract]   [Full Text] [Related]  

  • 15. When should stress ulcer prophylaxis be used in the ICU?
    Quenot JP; Thiery N; Barbar S
    Curr Opin Crit Care; 2009 Apr; 15(2):139-43. PubMed ID: 19578324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of stress ulcer: an essentially necessary measure in intensive care patients? Arguments contra].
    Hannemann L; Kuss B; Eyrich K
    Z Gastroenterol; 1991 Jan; 29 Suppl 1():7-8; discussion 9. PubMed ID: 1683735
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment on "Surviving sepsis campaign guidelines for the management of severe sepsis and septic shock" by Dellinger et al.
    Zandstra DF; van der Voort PH
    Intensive Care Med; 2004 Oct; 30(10):1984; author reply 1981. PubMed ID: 15278271
    [No Abstract]   [Full Text] [Related]  

  • 18. Stress Ulcer Prophylaxis: Who, When, and Why Stress Out About It?
    Larson A; Ahrndt S; Jansen T
    S D Med; 2016 Apr; 69(4):176-7. PubMed ID: 27263167
    [No Abstract]   [Full Text] [Related]  

  • 19. Evolving perspectives on parenteral H2-receptor antagonist therapy.
    Peura DA; Freston JW
    Am J Med; 1987 Dec; 83(6A):1-2. PubMed ID: 2892403
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.